Medicare Enrolled

Dr. Sonya Khan, MD

Internal Medicine · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
In practice since 2010 (15 years)
NPI: 1548574999 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khan

Dr. Sonya Khan is an internal medicine specialist in Houston, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 486 Medicare services across 430 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khan received a total of $9,594 from 54 pharmaceutical and/or device companies across 491 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ 486 Medicare services $9,594 industry payments

Medicare Practice Summary

Medicare Utilization ↗
486
Medicare services
Bottom 40% in TX for internal medicine
430
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 167 $70 $265
New patient office visit (45-59 min) 76 $97 $444
Office visit, established patient, complex (40-54 min) 57 $110 $536
Initial hospital admission, moderate complexity 46 $104 $518
Initial hospital admission, high complexity 46 $140 $677
Hospital follow-up visit, moderate complexity 40 $62 $226
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 33 $27 $129
New patient office visit, complex (60-74 min) 21 $139 $564
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,594
Total received (2018-2024)
Avg $1,371/year across 7 years
Top 9% in TX for internal medicine
54
Companies
491
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,666 (79.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,928 (20.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,229
2023
$343
2022
$115
2021
$31
2020
$2,390
2019
$2,365
2018
$2,121

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Corcept Therapeutics
$2,095
Lilly USA, LLC
$615
Zealand Pharma US, Inc.
$568
Novo Nordisk Inc
$541
Ascensia Diabetes Care Us Inc.
$523
SANOFI-AVENTIS U.S. LLC
$460
AstraZeneca Pharmaceuticals LP
$390
Amgen Inc.
$386
Amarin Pharma Inc.
$380
Valeritas, Inc.
$324
Dexcom, Inc.
$274
Companion Medical, Inc.
$206
Otsuka America Pharmaceutical, Inc.
$190
Alexion Pharmaceuticals, Inc.
$187
Boehringer Ingelheim Pharmaceuticals, Inc.
$180
Mannkind Corporation
$154
Tandem Diabetes Care, Inc.
$142
Abbott Laboratories
$131
Janssen Pharmaceuticals, Inc
$130
Radius Health, Inc.
$128
AbbVie, Inc.
$95
Kowa Pharmaceuticals America, Inc.
$92
Becton, Dickinson and Company
$82
Shire North American Group Inc
$82
GlaxoSmithKline, LLC.
$81
AbbVie Inc.
$77
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$76
Takeda Pharmaceuticals U.S.A., Inc.
$75
Insulet Corporation
$75
Currax Pharmaceuticals LLC
$74
Medtronic MiniMed, Inc.
$72
Regeneron Healthcare Solutions, Inc.
$63
EISAI INC.
$60
Axsome Therapeutics, Inc.
$59
Merck Sharp & Dohme Corporation
$52
Antares Pharma, Inc.
$48
LifeScan, Inc.
$45
Eisai Inc.
$42
IBSA Pharma Inc.
$38
MannKind Corporation
$35
Endo Pharmaceuticals Inc.
$32
Esperion Therapeutics, Inc.
$30
Mallinckrodt Enterprises LLC
$29
Genentech USA, Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$22
PFIZER INC.
$20
Gemini Laboratories, LLC
$19
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$15
Allergan Inc.
$15
Acerus Pharmaceuticals Corporation
$15
Acella Pharmaceuticals, LLC
$15
ABBVIE INC.
$13
Xeris Pharmaceuticals, Inc.
$12
Ultragenyx Pharmaceutical Inc.
$7
Top 3 companies account for 34.2% of total payments
Associated products mentioned in payments ›
ACTHAR · AFREZZA · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BYSTOLIC · Belviq · CONTRAVE · CRYSVITA · CYCLOSET · Corlanor · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DIABETES - DISEASE · Dexcom CGM · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · Esbriet · FARXIGA · FORTEO · FreeStyle Libre · Guardian Connect · HUMULIN · HUMULIN R 500 · INVOKANA · InPen · JANUVIA · JARDIANCE · JYNARQUE · Korlym · LINZESS · LifeVest · Livalo · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NP Thyroid · Natesto · OFEV · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Parsabiv · Prolia · RECORLEV · RYBELSUS · Repatha · SAMSCA · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SYNTHROID · Saxenda · Sogroya · Strensiq · Sunosi · Synthroid · TESTOPEL · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tresiba · Tymlos · UNITHROID · Uloric · V-GO · Vascepa · Victoza · XARELTO · XYOSTED · ZEGALOGUE · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in TX.

Equivalent to $1,974 per 100 Medicare services performed
Looking for an internal medicine specialist in Houston?
Compare internal medicine physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,667
Per 100K population
56.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Khan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of TX peers, with 15 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Khan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khan performed 167 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $9,594 from 54 companies across 491 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other internal medicine physicians in Houston?
Dr. Khan's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →